“…However, phosphorylation of FRS2 by FGFRs activates not only the PI3K/ AKT pathway (through Grb2/Gab1 binding; Ong et al, 2001), but also the MAPK/ERK pathway (through Grb2/Shp2 binding; Hadari et al, 1998). Indeed, deletion of FGFR1 and/or FGFR2 leads to decreases in phospho-MAPK/ERK and phospho-AKT levels (Emmenegger et al, 2013;Zhao et al, 2008;Cai et al, 2013;Hoch and Soriano, 2006;Loilome et al, 2009;Kondo et al, 2007), and overexpression of FGFR2b or FGFR1 increases both phospho-AKT and phospho-ERK levels (Cha et al, 2008;Freeman et al, 2003;Acevedo et al, 2007). It is known that crosstalk can occur between the PI3K/AKT and MAPK/ERK pathways (Moelling et al, 2002), thus, possibly, the MAPK/ERK pathway is being triggered congruently.…”